Multiple sclerosis and cancer: Navigating a dual diagnosis

Area of Science:

• Neuroscience
• Oncology
• Immunology

Background:

• Growing population of patients with both multiple sclerosis (MS) and cancer.
• Complex factors (age, genetics, treatments) confound understanding of MS and cancer risk.
• Existing research often prioritizes cancer survival over MS outcomes.

Purpose of the Study:

• To review literature on MS, cancer risk, and the interaction of disease-modifying therapies (DMTs) and cancer treatments.
• To explore strategies for managing MS in cancer survivors.
• To identify needs for future research and clinical guidelines.

Main Methods:

• Literature review of existing studies on MS, cancer risk, and treatment intersections.
• Analysis of the complexities in managing dual diagnoses.
• Identification of research gaps and clinical needs.

Main Results:

• The relationship between MS and cancer risk is complex and not fully understood.
• There is a need to better understand the impact of cancer treatments on MS and vice versa.
• Current management strategies require optimization for dual-diagnosis patients.

Conclusions:

• Optimizing care for cancer survivors with MS requires a comprehensive approach.
• Further research, including collaborative efforts and data collection (retrospective and prospective), is essential.
• Development of specific treatment guidelines is critical for neuro-immunology and oncology collaboration.